Safety and Effectiveness of Essential Phospholipids Paste in Patients with Non-alcoholic Fatty Liver Disease or Viral Hepatitis
- 22 September 2021
- journal article
- research article
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 32 (9), 750-757
- https://doi.org/10.5152/tjg.2021.20294
Abstract
Essential phospholipids,gastrointestinal dysfunction,liver disease,non-alcoholic fatty liver disease,phosphatidylcholineKeywords
This publication has 32 references indexed in Scilit:
- Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysisPatient Preference and Adherence, 2013
- Retracted: Natural course of nonalcoholic fatty liver disease in southern China: A prospective cohort studyJournal of Digestive Diseases, 2012
- Patient-reported outcomes: A new era in clinical researchPerspectives in Clinical Research, 2011
- Strategies to improve drug adherenceEuropean Heart Journal, 2010
- Quality of life in adults with nonalcoholic fatty liver disease: Baseline data from the nonalcoholic steatohepatitis clinical research networkJournal of Hepatology, 2009
- Symptomatology and health attitudes of chronic hepatitis B patients in the USAJournal of Viral Hepatitis, 2007
- Validation of a 7‐point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trialsAlimentary Pharmacology & Therapeutics, 2006
- Health-related quality of life of patients with gastrointestinal symptomsAlimentary Pharmacology & Therapeutics, 2004
- GSRS?A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer diseaseDigestive Diseases and Sciences, 1988
- Use of polyunsaturated phosphatidyl choline in HBsAg negative chronic active hepatitis: results of prospective double‐blind controlled trialLiver International, 1982